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ABSTRACT: Gastric cancer (GC) and pancreatic cancer (PC) are the third and seventh most likely cancers to cause death 
worldwide. We aimed to determine the dietary and lifestyle factors of patients with GC or PC and their associated risk 
among Jordanians. This case-control study enrolled 587 adults (patients with PC, 101; patients with GC, 172; healthy con-
trols, 314) between March 2015 and August 2018, who were assessed using interview-based personal and physical activ-
ity questionnaires. Multivariable logistic regression models were taken as measures for predictors of GC and PC risk. We 
showed that GC and PC patients had higher pre-diagnosis body-mass indexes, a greater proportion smoked and had a fam-
ily history of cancer than controls. Furthermore, consumption of two snacks [odds ratios (OR)=0.44, 95% confidence in-
tervals (CI): 0.23∼0.85], three snacks (OR=0.04, 95% CI: 0.01∼0.23) and no meals eaten outside (OR=0.31, 95% CI: 
0.09∼0.99) showed a protective effect against GC, and consumption of three snacks (OR=0.08, 95% CI: 0.02∼0.40) re-
duced significantly the risk of PC. These results suggest that bodyweight, physical activity, smoking, and family history of 
cancer are among factors that affect GC and PC risk among Jordanians.
Keywords: body mass index, gastric cancer, pancreatic cancer, physical activity, smoking
INTRODUCTION
Gastric cancer (GC) is the third most common type of 
cancer to cause death and the fifth most common type 
worldwide (Ferlay et al., 2015). From 2007 to 2016, the 
incidence rate for pancreatic cancer (PC) increased by 
0.7% per year in white individuals and 0.3% per year in 
black individuals (American Cancer Society, 2020). How-
ever, from 2008 to 2017, mortality trends demonstrated 
a slight increase in death rate for PC (by 0.4% per year) in 
white individuals and a slight decrease (by 0.5% per year) 
in black individuals (American Cancer Society, 2020).
GC (Carcas, 2014) and PC (Costello, 2018) are hetero-
geneous diseases that are commonly diagnosed in their 
late stages (Lee and Derakhshan, 2013). Therefore, care-
ful attention should be given to prevent GC and PC de-
velopment since prevention and early diagnosis are vital 
approaches for controlling and reducing mortality rates 
(American Cancer Society, 2020).
Established risk factors for gastric and pancreatic can-
cers include smoking, excess body weight, high salt in-
take, alcohol, physical activity, and infection by Helico-
bacter pylori (American Cancer Society, 2020). However, 
studies show contrasting results, some documenting that 
smoking decreases survival (Zhao et al., 2020) and others 
showing no significant association (Trivers et al., 2005; 
Sundelöf et al., 2008; Ferronha et al., 2012). An esti-
mated 5% of cancers in men and 11% in women are re-
lated to excess body weight (Islami et al., 2018). Excess 
body weight (i.e., being overweight or obese) is associa-
ted with an increased risk of many types of cancers, in-
cluding gastric and pancreatic cancers (American Cancer 
Society, 2020).
An estimated 3% of cancer cases are attributed to phys-
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ical inactivity (Islami et al., 2018). Physical activity is as-
sociated with a reduced risk of stomach and pancreatic 
cancers (World Cancer Research Fund/American Insti-
tute for Cancer Research, 2018). A greater amount of sed-
entary behaviour may increase risk of several types of can-
cers, including GC and PC (2018 Physical Activity Guide-
lines Advisory Committee, 2018). Furthermore, cancer 
patients who are physically active are less likely to have 
adverse effects and die from cancers than those who are 
inactive (Cormie et al., 2017). In Jordan, no previous 
studies have evaluated the associations between GC or 
PC and possible modifiable and non-modifiable risk fac-
tors. The present study was conducted to investigate the 
potential association between these lifestyle factors and 
dietary habits and the risk of GC or PC among Jordani-
ans.
MATERIALS AND METHODS
Study design and participants
This case-control study was conducted in Jordan between 
March 2015 and August 2018. In total, 114 patients with 
medically confirmed PC and 186 patients with medically 
confirmed GC were invited to participate, and 101 pa-
tients with PC and 172 patients with GC enrolled. The 
control group consisted of 314 individuals without PC and 
GC, who were conveniently selected from the commun-
ity. Population-based controls were frequency matched to 
cases based on age, gender, occupation, and marital sta-
tus.
Inclusion criteria included Jordanian nationality, aged 
18 years or older at enrolment, able to communicate ver-
bally, and absence of any chronic diseases that require di-
etary modifications, such as kidney disease, liver disease, 
and celiac disease. For the GC and PC cases, patients must 
have been diagnosed within the last six months. Exclu-
sion criteria included individuals who were critically ill, 
hospitalized, or unable to communicate verbally. Informed 
consent was obtained from all participants before enrol-
ment.
Cases were enrolled from four hospitals: King Hussein 
Cancer Center, King Abdullah University Hospital, Jordan 
University Hospital, and Al-Bashir Hospital. The study 
protocol conformed to the ethical guidelines of the 1975 
Declaration of Helsinki and was approved by the Ethics 
Committee of the King Hussein Cancer Center (IRB No. 
15 KHCC 03, Amman, Jordan).
Data collection
Data were obtained by completing personal and physical 
activity questionnaires, which were completed during 
face-to-face interviews and filed by trained research as-
sistants.
The personal questionnaire included questions related 
to age, gender, marital status, educational attainment, 
employment status, family income/month, smoking sta-
tus, previous and current health problems, family history 
of cancer, and the presence or absence of stomach pain 
and ulcers. Smoking status included non-smoker, current 
smoker, previous smoker, and passive smoker (second- 
hand smoker) (Thornton et al., 1994). Information about 
dietary habits, such as consumption of main meals and 
snacks, frequency of skipping meals (breakfast, lunch, or 
dinner), frequency of eating problems, and daily water 
intake were also collected.
Anthropometric measurements
Participants’ current body weight and height were meas-
ured using standardized techniques and calibrated tools 
by trained research assistants. Body weight was measured 
to the nearest 0.1 kg with minimal clothing and without 
shoes using a calibrated scale (seca GmbH & Co. KG, 
Hamburg, Germany). Height was measured to the nearest 
cm when participants in the full standing position with-
out shoes using a calibrated measuring rod (seca GmbH 
& Co. KG). Body mass index (BMI) was computed as the 
ratio of weight (kg) to height squared (m) (Lee and Nie-
man, 2013), and classified according to World Health Or-
ganization guidelines (WHO, 2002). However, the usual 
body weight at pre-diagnosis was self-reported from the 
cases and controls.
Physical activity questionnaire
A validated 7-day Physical Activity Recall (PAR) ques-
tionnaire was used to estimate participant’s physical ac-
tivity levels. The 7-day PAR is a structured questionnaire 
that depends on participant’s recall of time spent on 
physical activity over a 7-day period (Sallis et al., 1985). 
It assesses physical activity intensity (e.g. from aerobic 
exercise, work-related activities, walking, gardening, rec-
reation, and leisure activities). The frequency, intensity, 
duration, and type of physical activity are typically taken 
into consideration to estimate the level of physical activ-
ity. The number of hours spent sleeping and undertak-
ing different levels of activity levels were assessed and 
converted into metabolic equivalents (MET). According 
to the scoring instructions, sleeping was assigned a value 
of 1.0 MET, light activity a value of 1.5 METs, moderate 
activity a value of 4.0 METs, and very hard activity a value 
of 7.0 METs or greater (Thompson et al., 1982). Physi-
cal activity was calculated as the time (min) dedicated to 
each activity multiplied by the calculated MET and mul-
tiplied by the number of days the activity was under-
taken during the week, as follows: MET level × min of 
activity/day × days per week (Sallis et al., 1985). Physi-
cal activity level was expressed as continuous data in 
MET-min/week, and as categorical scores [inactive, min-
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Table 1. Characteristics of the study participants
Gastric cancer cases 
(n=172)
Pancreatic cancer 
cases (n=101) Controls (n=314) P-value
Age (years) 54.1±1.0 56.97±1.2 54.0±0.7 0.093
Height (cm) 167.9±0.7 166.2±0.9 168.0±0.5 0.228
Pre-diagnosis body weight (kg) 85.3±1.6a 83.4±2.0ab 79.4±1.2b 0.009
Current weight (kg) 70.6±1.3b 69.4±1.4b 80.9±0.9a 0.001
Pre-diagnosis BMI (kg/m2) 30.1±0.5a 30.2±0.7a 28.3±0.4b 0.008
Current BMI (kg/m2) 25.0±0.5b 25.1±0.5b 28.7±0.3a 0.001
Income (JD) 674.0±79.6 700.1±74.7 575.9±36.0 0.266
Number of cigarettes/d 13.5±1.6a 10.8±1.6ab 9.0±0.9b 0.028
Duration of smoking (years) 12.4±17.1a 13.1±26.7a 8.8±14.7b 0.036
Total physical activity (MET-min/week)1) 1,031.5±42.7b 952.9±47.2b 1,314.7±45.6a 0.001
1)Inactive: not fitting in "minimally active [at least 600 metabolic equivalents (MET)-min/week]" or "HEPA active (more than 3,000 
MET-min/week)".
Each value is represented as mean±SEM.
Means with different letters (a,b) within the same row are significantly different (P<0.05).
BMI, body mass index; JD, Jordan dinar.
imally active, and Health-Enhancing Physical Activity 
(HEPA) active] based on the standard scoring protocol 
of International Physical Activity questionnaire. Partici-
pants were considered inactive if their activity levels were 
too low to meet creteria of minimally active or HEPA ac-
tive. The minimally active category included participants 
who met any of the following conditions: (1) vigorous 
activity on 3 or more days for at least 20 min per day; (2) 
moderate intensity activity or walking on 5 or more days 
for at least 30 min per day, or (3) vigorous intensity ac-
tivities on 5 or more days, achieving a minimum of 600 
MET-min/week. The HEPA active catogory included par-
ticipants who performed either vigorous intensity activity 
on at least 3 days and accumulated at least 1,500 MET- 
min/week, or participants who performed a combination 
of walking, moderate intensity or vigorous intensity ac-
tivities on at least 7 days, achieving a minimum of at 
least 3,000 MET-min/week (Forde, 2018).
Statistical analysis
Statistical analysis was performed using the Statistical 
Package for the Social Sciences (SPSS) version 27 (IBM 
Corporation, Armonk, NY, USA). Frequencies and per-
centages were calculated to describe categorical variables. 
Pearson chi-square tests was used to detect differences 
in personal characteristics, lifestyle variables, and eating 
habits among study participants. Means and standard er-
ror of the mean (SEM) were calculated for the continuous 
variables. One-way analysis of variance (ANOVA) and 
Fisher’s least significant difference post hoc tests were 
used to calculate differences in continuous variables be-
tween gastric and pancreatic cases and controls. The sig-
nificance level was set at P<0.05. Odds ratios (OR) and 
95% confidence intervals (CI) from multivariable logistic 
regression models were taken as measures for predictors 
of gastric and pancreatic cancers risk.
RESULTS
Table 1 shows the characteristics of participants with GC 
(n=172) and PC (n=101), and controls (n=314). Partic-
ipants with GC and PC had a similar age, height, and in-
come as controls. The pre-diagnosis BMI for participants 
with both GC and PC were significantly higher than con-
trols. However, current body weight and BMI for both 
types of cancer were significantly lower than for controls.
The number of cigarettes smoked per day was 13.5±1.6 
for participants with GC, 10.8±1.6 for participants with 
PC, and 9.0±0.9 for controls. The number of cigarette 
smokers in the GC group was significantly higher than 
for controls. The duration of smoking was 12.4±17.1 and 
13.1±26.7 years for GC and PC cases, respectively, and 
was significantly higher than for controls (8.8±14.7 
years). Total physical activity METs (MET-min/week) 
were 1,031.5±42.7, 952.9±47.2, and 1,314.7±45.6 for 
GC and PC cases, and controls, respectively. However, all 
participants were considered minimally active (Table 1).
Table 2 shows the demographic and lifestyle factors of 
participants with GC and PC, and controls. Most GC cases 
(57.1%) and PC cases (52.6%) were considered normal 
according to their BMIs. However, most were previously 
considered overweight (GC, 40.4%; PC, 41.1%) or obese 
(GC, 41.0%; PC, 41.1%). The Majority of GC (67.9%) and 
PC (73.9%) cases were considered stage 4.
The total number of participants who smoked (includ-
ing current, previous, and passive smokers) was signifi-
cantly higher for GC (52.0%) and PC (46.5%) cases than 
controls (39.5%). However, no significant difference was 
detected in the daily number of cigarettes smoked by the 
subjects amongst study groups.
A greater number of participants with GC (48.6%) and 
PC (48.5%) had a family history of cancer compared with 
the control group (31.8%). Participants with GC reported 
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Table 2. Demographic and lifestyle factors of patients with gastric cancer and pancreatic cancer






  Male 107 (61.8%) 59 (58.4%) 191 (60.8%)
  Female 66 (38.2%) 42 (41.6%) 123 (39.2%)
Pre-diagnosis BMI categories 0.163
  <18.5 0 (0.0%) 1 (1.1%) 6 (2.1%)
  18.5∼24.9 29 (18.6%) 16 (16.8%) 73 (25.9%)
  25.0∼29.9 63 (40.4%) 39 (41.1%) 97 (34.4%)
  >30.0 64 (41.0%) 39 (41.1%) 106 (37.6%)
  Missing1) 17 6 32
Current BMI categories 0.001
  <18.5 9 (5.8%) 6 (6.2%) 0 (0.0%)
  18.5∼24.9 89 (57.1%) 51 (52.6%) 85 (27.8%)
  25.0∼29.9 30 (19.2%) 21 (21.6%) 108 (35.3%)
  >30.0 28 (17.9%) 19 (19.6%) 113 (36.9%)
  Missing 17 4 8
Cancer stages 0.001
  No cancer 0 (0.0%) 0 (0.0%) 314 (100.0%)
  Stage 1 0 (0.0%) 1 (1.1%) 0 (0.0%)
  Stage 2 2 (1.4%) 1 (1.1%) 0 (0.0%)
  Stage 3 43 (30.7%) 21 (23.9%) 0 (0.0%)
  Stage 4 95 (67.9%) 65 (73.9%) 0 (0.0%)
  Missing 33 13 0
Marital status 0.714
  Married 148 (85.5%) 87 (86.1%) 273 (86.9%)
  Single 8 (4.6%) 5 (5.0%) 20 (6.4%)
  Divorced 3 (1.7%) 3 (3.0%) 7 (2.2%)
  Widowed 14 (8.1%) 6 (5.9%) 14 (4.5%)
Education level 0.348
  Illiterate 10 (5.8%) 7 (6.9%) 18 (5.8%)
  Less than high school 54 (31.4%) 24 (23.8%) 80 (25.6%)
  High school 43 (25.0%) 14 (13.9%) 72 (23.0%)
  Diploma 25 (14.5%) 18 (17.8%) 56 (17.9%)
  Bachelor 34 (19.8%) 30 (29.7%) 71 (22.7%)
  Master’s degree 4 (2.3%) 5 (5.0%) 13 (4.2%)
  Doctorate degree 2 (1.2%) 3 (3.0%) 3 (1.0%)
  Missing 1 0 1
Employment status 0.778
  Yes 82 (47.7%) 45 (45.0%) 153 (49.0%)
  No 90 (52.3%) 55 (55.0%) 159 (51.0%)
  Missing 1 1 2
Smoking status 0.001
  Total number of the smokers 90 (52.0%) 47 (46.5%) 124 (39.5%)
    Current smoker 56 (32.4%) 38 (37.6%) 99 (31.5%)
    Previous smoker 23 (13.3%) 3 (3.0%) 13 (4.1%)
    Passive smoker 11 (6.3%) 6 (5.9%) 12 (3.8%)
    Non-smoker 83 (48.0%) 54 (53.5%) 190 (60.5%)
Number of cigarettes/d 0.467
  <1 95 (56.2%) 60 (60.0%) 206 (65.6%)
  2∼5 6 (3.6%) 3 (3.0%) 12 (3.8%)
  6∼10 5 (3.0%) 3 (3.0%) 12 (3.8%)
  11∼20 23 (13.6%) 17 (17.0%) 42 (13.4%)
  21∼40 28 (16.6%) 12 (12.0%) 29 (9.2%)
  >41 12 (7.1%) 5 (5.0%) 13 (4.1%)
  Missing 4 1 0
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Table 2. Continued






  Smoker 7 (4.0%) 6 (5.9%) 27 (8.6%)
  Non-smoker 163 (94.2%) 93 (92.1%) 282 (89.8%)
  Previous smoker 3 (1.7%) 2 (2.0%) 5 (1.6%)
Hookah smoking/d 0.381
  0 163 (97.6%) 93 (93.9%) 284 (93.7%)
  1 3 (1.8%) 5 (5.1%) 13 (4.3%)
  ≥2 1 (0.6%) 1 (1.0%) 6 (2.0%)
  Missing 6 2 11
Health problem 0.195
  No 95 (54.9%) 45 (44.6%) 151 (48.1%)
  Yes 78 (45.1%) 56 (55.4%) 163 (51.9%)
Type of health problem 0.004
  No 95 (54.9%) 45 (44.6%) 151 (48.1%)
  Diabetes mellitus 33 (19.1%) 36 (35.6%) 81 (25.8%)
  Heart 10 (5.8%) 10 (9.9%) 19 (6.1%)
  Hypertension 30 (17.3%) 9 (8.9%) 40 (12.7%)
  Other 5 (2.9%) 1 (1.0%) 23 (7.3%)
Family history of cancer 0.001
  Yes 84 (48.6%) 49 (48.5%) 100 (31.8%)
  No 89 (51.4%) 52 (51.5%) 214 (68.2%)
Cancer type for patient’s family 0.001
  Absent 89 (51.4%) 52 (51.5%) 214 (68.2%)
  Gastric 7 (9.8%) 4 (4.0%) 10 (3.2%)
  Colon and/or rectal 9 (5.2%) 1 (1.0%) 13 (4.1%)
  Pancreatic 1 (0.6%) 3 (3.0%) 1 (0.3%)
  Bone cancer 4 (2.3%) 3 (3.0%) 6 (1.9%)
  Lung 5 (2.9%) 6 (5.9%) 11 (3.5%)
  Leukaemia 3 (1.7%) 1 (1.0%) 10 (3.2%)
  Breast 16 (9.2%) 7 (6.9%) 13 (4.1%)
  Liver 6 (3.5%) 4 (4.0%) 5 (1.6%)
  Prostate 2 (1.2%) 6 (5.9%) 4 (1.3%)
  Other 21 (12.1%) 14 (13.9%) 27 (8.6%)
  Missing 39 24 36
Stomach pain 0.001
  Yes 49 (28.3%) 9 (9.0%) 14 (4.5%)
  No 124 (71.7%) 91 (91.0%) 300 (95.5%)
  Missing 0 1 0
Stomach ulcer 0.001
  Yes 77 (44.8%) 13 (13.0%) 5 (1.6%)
  No 95 (55.2%) 87 (87.0%) 309 (98.4%)
  Missing 1 1 0
Physical activity levels2) 0.001
  Inactive 50 (29.1%) 26 (26.0%) 46 (14.6%)
  Minimally active 122 (70.9%) 73 (73.0%) 251 (79.9%)
  HEPA active 0 (0.0%) 1 (1.0%) 17 (5.4%)
  Missing 1 1 0
1)The response base differs as some cases had either irrelevant responses or no response at all.
2)Inactive: not fitting in "minimally active [at least 600 metabolic equivalents (MET)-min/week]" or "HEPA active (more than 3,000 
MET-min/week)".
family histories of gastric (9.8%), colon and/or rectal 
(5.2%), breast (9.2%), and other (12.1%) cancers. How-
ever, participants with PC reported family histories of 
lung (5.9%), breast (6.9%), prostate (5.9%), and other 
(13.9%) cancers. Approximately 28.3% and 44.8% of par-
ticipants with GC suffered from stomach pain and stom-
ach ulcers, respectively. Despite significantly different lev-
els of physical activity between groups, participants with 
GC and PC and controls were all considered minimally 
active (Table 2).
Table 3 illustrates dietary habits of participants with 
GC and PC and controls. In total, 38.2% of participants 
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Table 3. Dietary habits of gastric and pancreatic cancer patients





Number of main meals 0.019
  One meal 10 (5.8%) 7 (6.9%) 25 (8.0%)
  Two meals 66 (38.2%) 36 (35.6%) 152 (48.4%)
  Three meals 95 (54.9%) 58 (57.4%) 129 (41.1%)
  More than three meals 2 (1.2%) 0 (0.0%) 8 (2.5%)
Skipped meals 0.057
  No 97 (56.1%) 55 (55.0%) 138 (44.1%)
  Breakfast 22 (12.7%) 11 (11.0%) 34 (10.9%)
  Lunch 5 (2.9%) 8 (8.0%) 13 (4.2%)
  Dinner 38 (22.0%) 19 (19.0%) 85 (27.2%)
  Breakfast and lunch 4 (2.3%) 2 (2.0%) 21 (6.7%)
  Breakfast and dinner 5 (2.9%) 5 (5.0%) 19 (6.1%)
  Lunch and dinner 2 (1.2%) 0 (0.0%) 3 (1.0%)
  Missing1) 0 1 1
Number of snacks 0.002
  One 79 (45.7%) 42 (42.0%) 111 (35.7%)
  Two 56 (32.4%) 37 (37.0%) 117 (37.6%)
  Three 2 (1.2%) 2 (2.0%) 32 (10.3%)
  More than three 2 (1.2%) 1 (1.0%) 5 (1.6%)
  No 34 (19.7%) 18 (18.0%) 46 (14.8%)
  Missing 0 1 3
Number of meals eaten outside 0.001
  No 42 (24.3%) 25 (24.8%) 119 (37.9%)
  Less than once/month 34 (19.7%) 24 (23.8%) 85 (27.1%)
  1∼3 times/month 35 (20.2%) 25 (24.8%) 62 (19.7%)
  1∼3 times/week 43 (24.9%) 20 (19.8%) 32 (10.2%)
  4∼6 times/week 12 (6.9%) 4 (4.0%) 5 (1.6%)
  Daily 7 (4.0%) 3 (3.0%) 11 (3.5%)
Daily water amount 0.002
  1∼3 cups 36 (20.9%) 23 (22.8%) 28 (8.9%)
  3∼5 cups 51 (29.7%) 33 (32.7%) 103 (32.9%)
  More than 5 cups 83 (48.3%) 45 (44.6%) 181 (57.8%)
  I don’t know 2 (1.2%) 0 (0.0%) 1 (0.3%)
  Missing 1 0 4
Eating problem 0.001
  No 131 (75.7%) 84 (83.2%) 281 (89.5%)
  Yes 42 (24.3%) 17 (16.8%) 33 (10.5%)
Type of eating problem 0.001
  Swallowing 7 (4.0%) 3 (3.0%) 10 (3.2%)
  Not feeling the taste and 
  smell of the food
4 (2.3%) 0 (0.0%) 5 (1.6%)
  Loss of appetite 3 (1.7%) 4 (4.0%) 9 (2.9%)
  Way of eating 3 (1.7%) 1 (1.0%) 1 (0.3%)
  Add salt 19 (11.0%) 5 (5.0%) 5 (1.6%)
  Chewing 5 (2.9%) 4 (4.0%) 2 (0.6%)
  Vomiting 1 (0.6%) 0 (0.0%) 1 (0.3%)
  No 131 (75.7%) 84 (83.2%) 281 (89.5%)
1)The response base differs as some cases had either irrelevant responses or no response at all.
with GC and 35.6% of participants with PC consumed 
two main meals/d, compared with 48.4% of controls. 
Over half of participants with GC and PC consumed three 
main meals/d, compared with only 41.1% for controls. 
For participants in all groups, breakfast and dinner were 
the most frequently skipped meals. Furthermore, the 
number of snacks consumed daily and the number of 
meals consumed outside significantly differed between 
participants with GC and PC and controls. In addition, 
participants with GC and PC consumed significantly less 
water daily than controls (consumption of more than 5 
cups of water daily: GC cases, 48.3%; PC cases, 44.6%; 
controls, 57.8%). The number and types of eating prob-
lems significantly differed between groups.
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Table 4. Logistic regression analysis of potential predictors of gastric and pancreatic cancer
Potential predictors






Lower Upper Lower Upper
Cancer type for patient’s family
  Gastric 2.30 0.79 6.72 0.127 0.71 0.17 2.91 0.635
  Colon and/or rectal 0.85 0.27 2.66 0.774 0.10 0.01 0.91 0.041
  Pancreatic 1.53 0.04 52.66 0.814 6.86 0.23 206.04 0.267
  Bone cancer 1.66 0.33 8.44 0.538 1.51 0.26 8.95 0.648
  Lung 0.59 0.15 2.30 0.443 1.06 0.27 4.10 0.932
  Leukaemia 0.36 0.07 1.71 0.196 0.22 0.02 2.06 0.184
  Breast 1.44 0.49 4.23 0.506 1.08 0.31 3.75 0.909
  Liver 1.01 0.23 4.43 0.991 0.96 0.19 4.81 0.962
  Prostate 0.34 0.05 2.26 0.262 2.18 0.46 10.27 0.324
  Other 1 Referent 1 Referent
Number of main meals
  One meal 0.29 0.04 2.29 0.240 − − − −
  Two meals 0.35 0.05 2.33 0.279 − − − −
  Three meals 0.80 0.13 5.16 0.816 − − − −
  More than three meals 1 Referent 1 Referent
Number of snacks
  One 0.62 0.33 1.14 0.125 0.71 0.34 1.49 0.364
  Two 0.44 0.23 0.85 0.015 0.49 0.23 1.08 0.076
  Three 0.04 0.01 0.23 0.001 0.08 0.02 0.40 0.002
  More than three 0.16 0.02 1.11 0.064 0.18 0.02 2.14 0.175
  No 1 Referent 1 Referent
Number of meals eaten outside
  No 0.31 0.09 0.99 0.048 0.4 0.09 1.89 0.249
  Less than once/month 0.39 0.12 1.29 0.123 0.81 0.17 3.83 0.792
  1∼3 times/month 0.53 0.16 1.71 0.286 1.07 0.23 5.02 0.932
  1∼3 times/week 1.95 0.59 6.47 0.273 2.51 0.52 12.11 0.252
  4∼6 times/week 3.40 0.74 15.70 0.117 3.24 0.44 23.62 0.247
  Daily 1 Referent 1 Referent
1)Adjusted for: age, gender, smoking status, family history of cancer, health problem, type of health problem and physical activity.
Table 4 shows that the odd ratios for consumption of 
two snacks (OR=0.44, 95% CI: 0.23∼0.85), three snacks 
(OR=0.04, 95% CI: 0.01∼0.23), and no meals outside 
(OR=0.31, 95% CI: 0.09∼0.99) were inversely associat-
ed with GC risk. Furthermore, the risk of PC were in-
versely associated with the odds of a family history of co-
lon and/or rectal cancer (OR=0.10, 95% CI: 0.01∼0.91) 
and consumption of three snacks (OR=0.08, 95% CI: 
0.02∼0.40).
DISCUSSION
This study aimed to assess the main demographic and 
lifestyle factors of participants with GC and PC. Further-
more, it aimed to investigate the association between 
these lifestyle factors and dietary habits and the risk of 
GC and PC among Jordanians.
Many risk factors associated with GC and PC. Being 
overweight or obese increases the risk of many cancers, 
therefore obtaining and maintaining a healthy weight 
may lower the risk. Our study showed that both weight 
at diagnosis and BMI were reduced in participants with 
GC and PC compared with pre-diagnosis. Most partici-
pants with GC (57.1%) and PC (52.6%) had a BMI range 
of 18.5∼24.9, which is considered normal. This could 
be attributed to weight loss resulting from the diseases. 
A similar result was reported by Okada et al. (2017) who 
found that 69.1% of GC patients had a normal BMI in 
range of 18.5∼24.9 (Okada et al., 2017). However, 
Bosetti et al. (2013) found that 39.1% of participants 
with PC had a BMI of 20∼25.
Smoking is the most important risk factor for GC and 
PC. Both the number of cigarettes smoked per day and 
the duration of smoking in years were higher for partic-
ipants with GC and PC compared with controls. The to-
tal of participants who smoked (current, previous, and 
passive smokers) was 52% for participants with GC and 
46.5% for participants with PC. Similarly, previous stud-
ies have shown that a high percentage (66.3%) of pa-
tients with GC is smokers (Okada et al., 2017) and that 
48% of PC patients are current or previous smokers 
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(Keane et al., 2014). Further studies have reported that 
PC is not affected by smoking (OR=0.60, 95% CI: 0.30 
∼1.19, P=0.141) (Jo et al., 2015), and that active and 
passive smoking may play an important role in the de-
velopment of cardial stomach cancer (Mao et al., 2002). 
However, Duan et al. (2009) did not report any evidence 
that passive smoking had any appreciable effect on oeso-
phageal or gastric adenocarcinomas.
Regular physical activity may lower cancer risk. Several 
studies have demonstrated that avoiding a sedentary life-
style and participating in physical activities is helpful for 
reducing the risk of digestive system cancers (Tayyem et 
al., 2013; Tajabadi et al., 2019). In the current study, 
most participants with GC and PC (70.9% and 73.0%, 
respectively) were considered minimally active (physical 
activity level between 600∼3,000 MET-min/week) and 
were significantly less active than the control group. Sim-
ilarly, Zhang et al. (2009) showed that participants with 
PC were less physically active than controls. Tajabadi et 
al. (2019) stated that the type and intensity of physical 
activity associated with a protective effect against gastro- 
intestinal cancer is unknown. Furthermore, the exact un-
derlying mechanisms linking physical activity to digestive 
system cancers are unknown. However, different mecha-
nisms have been suggested. Physical activity may reduce 
growth factor 1 levels, which is associated with carcino-
genesis, reduce leptin and increases adiponectin levels in 
serum, regulate hormones in blood circulation, increase 
sex hormone binding protein levels, promote anti-oxidant 
defence, and modulate immune system function. Further-
more, water intake due to physical activity may be asso-
ciated with digestive system cancer risk. Water plays a 
role in softening content in the gut, thus increasing waste 
particle transit time and diluting carcinogens that can de-
crease the risk of colorectal cancer (Tajabadi et al., 2019).
Approximately 55.4% of participants with PC suffered 
from other health problems, the most common of which 
was diabetes mellitus (35.6%). Previously, Zhang et al. 
(2009) found that 27% of patients with PC suffered from 
diabetes mellitus, whereas Bosetti et al. (2013) showed 
that 18.5% of patients with PC had diabetes mellitus. 
Our study revealed that 9.9% of participants with PC suf-
fered from heart problems. However, researchers in the 
field of PC have stated that use of beta-blockers used in 
heart failure may suppress cancer invasion and prolifera-
tion (Zhang et al., 2010).
Moreover, 48.6% of participants with GC and 48.5% 
of participants with PC had a family history of cancer. 
Previous studies have shown a family history of cancer 
increases risk of GC (Gajalakshmi and Shanta, 1996) and 
PC (McGuigan et al., 2018). However, a family history of 
colon and/or rectal cancer was inversely associated with 
PC (OR=0.10, 95% CI: 0.01∼0.91). This may be attrib-
uted to the lower number of colon and/or rectal cancers 
recorded in our study. Consistent with our findings, 
Silverman (2001) found that a family history of cancer is 
associated with a 30% increase in risk of PC. Silverman 
(2001) showed that subjects with a family history of PC 
(OR=3.2) and colon cancer (OR=1.7) had a significantly 
higher risk of PC. In the current study, stomach pain and 
ulcers were significantly higher in both participants with 
GC and PC than controls. Several previous studies have 
shown that stomach pain and ulcers are significantly 
higher in patients with PC (Bosetti et al., 2013; Keane et 
al., 2014).
Most participants with cancer consumed three main 
meals and one snack per day. However, the American 
Cancer Society recommends that cancer patients instead 
eat several small snacks throughout the day (Rock et al., 
2012). We found that consuming two snacks (OR=0.44, 
95% CI: 0.23∼0.85) and three snacks (OR=0.04, 95% 
CI: 0.01∼0.23) decreased the risk of GC. Furthermore, 
consuming three snacks (OR=0.08, 95% CI: 0.02∼0.40) 
was associated with a lower risk of PC. Dinner was the 
most skipped meal for participants with GC and PC. In 
contrast to this result, Lim et al. (2012) reported that 
breakfast was the most skipped meals for patients with 
GC in Korea. Furthermore, in the current study, the 
numbers of meals eaten outside by participants with GC 
and PC were significantly higher than for controls. As 
expected, we found that not eating meals outside (OR= 
0.31, 95% CI: 0.09∼0.99) decreased the risk of GC. In 
addition, excessive consumption of salt can increase risk 
of GC (Okada et al., 2017). In this study, adding salt to 
food was the most predominant eating problem reported 
by participants with GC.
Several studies have shown that water intake may play 
a role in reducing the risk of some digestive cancers. Wa-
ter helps soften gut content, to increase waste particle 
transit time and dilute carcinogens, both of which de-
crease the risk of colorectal cancer (Tayyem et al., 2013; 
Tajabadi et al., 2019). In this study, fewer participants 
with cancer consumed more than 5 cups of water per day 
than controls.
The strengths of this study include the population- 
based design, relatively large sample size, and separate 
investigation of GC and PC cases. Furthermore, this is 
the first study to evaluate GC and PC risk factors using a 
case-control study among Jordanians. Our study also had 
several limitations. For example, data may be subject to 
recall bias, and several factors associated with GC and 
PC were not measured (e.g. H. pylori infection).
In conclusion, the data of this study suggest that differ-
ent dietary and lifestyle factors affect risk of GC and PC. 
Indeed, there was an association between certain lifestyle 
factors, dietary habits and risk of GC and PC among Jor-
danians. Our findings offer insight for further prospective 
investigations and for creating effective strategy to pre-
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vent GC and PC.
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